Gene Variant Tied to Risk for Interstitial Lung Disease in Rheumatoid Arthritis
For patients with rheumatoid arthritis, the MUC5B variant is associated with an increased risk for RA-associated interstitial lung disease.
Restrictive Lung Disease
In Idiopathic Pulmonary Fibrosis, 4 Comorbidity Clusters May Reflect Phenotypes
Researchers in Denmark assessed the real-world prevalence of multimorbidity among adults with idiopathic pulmonary fibrosis.
Role of Gastroprotective, Promotility Agents in SSc-Interstitial Lung Disease
Do gastroprotective and promotility agents prevent incident interstitial lung disease in patients with systemic sclerosis?
Diagnosing Usual Interstitial Pneumonia via Endobronchial Optical Coherence Tomography
A study compared the diagnostic accuracy of endobronchial OCT in interstitial lung disease to the clinical judgment of blinded, independent pathologists and pulmonologists.
Effect of Pirfenidone vs Nintedanib on Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Investigators assessed the effect of pirfenidone and nintedanib on the risk for acute exacerbation of idiopathic pulmonary fibrosis in patients undergoing treatment with these antifibrotic agents.
Study Finds Patients Adherent to Home Mechanical Ventilation for Chronic Obstructive Pulmonary Disease
Investigators describe current practices and clinical characteristics of patients with chronic obstructive pulmonary disease undergoing home mechanical ventilation.
Nasal High-Flow Oxygen Improves Exercise Capacity for Interstitial Lung Disease
A study evaluated the effect of nasal high-flow oxygen vs standard oxygen supplementation during exercise in patients with ILD.
Pulmonary Sarcoidosis Not Associated With Worse COVID-19-Related Outcomes
A team of investigators compared outcomes following COVID-19 in patients with and without pulmonary sarcoidosis.
Assessing Mortality in Rheumatoid Arthritis-Related Interstitial Lung Disease
Researchers assessed mortality rates in rheumatoid arthritis-related interstitial lung disease as well as the association between mortality, radiographic patterns, and confounding factors.
Switching Antifibrotic Agents May Improve Outcomes in Idiopathic Pulmonary Fibrosis
Because the 2 antifibrotics in use — pirfenidone and nintedanib — have differing mechanisms of action, when one is ineffective the other may provide benefit, thus improving survival.
- Loading...
Loading...
Next post in Restrictive Lung Disease
Loading... 
Loading...